BioLineRx recently announced that it has enrolled the first patient in a phase II study of BL-8040, for the treatment of acute myeloid leukemia .
http://www.investopedia.com/stock-analysis/zacks/060713/biolinerx-enrolls-first-patient-study-analyst-blog-blrx-snts-slxp-jazz.aspx?partner=rss_headlines
http://www.investopedia.com/stock-analysis/zacks/060713/biolinerx-enrolls-first-patient-study-analyst-blog-blrx-snts-slxp-jazz.aspx?partner=rss_headlines
No comments:
Post a Comment